|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 14, Issue 3, 848-857, March 2003
Pulmonary Vascular Biology Laboratory, Providence Veterans
Affairs Medical Center, Brown Medical School, Providence, Rhode Island
02908
Extracellular ATP, adenosine (Ado), and adenosine plus homocysteine
(Ado/HC) cause apoptosis of cultured pulmonary artery endothelial cells
through the enhanced formation of intracellular S-adenosylhomocysteine and disruption of focal adhesion
complexes. Because an increased intracellular ratio of
S-adenosylhomocysteine/S-adenosylmethionine favors inhibition of methylation, we hypothesized that Ado/HC might act
by inhibition of isoprenylcysteine-O-carboxyl
methyltransferase (ICMT). We found that
N-acetyl-S-geranylgeranyl-L-cysteine
(AGGC) and
N-acetyl-S-farnesyl-L-cysteine
(AFC), which inhibit ICMT by competing with endogenous substrates for
methylation, caused apoptosis. Transient overexpression of ICMT
inhibited apoptosis caused by Ado/HC, UV light exposure, or tumor
necrosis factor-
. Because the small GTPase, Ras, is a substrate for
ICMT and may modulate apoptosis, we also hypothesized that inhibition
of ICMT with Ado/HC or AGGC might cause endothelial apoptosis by
altering Ras activation. We found that ICMT inhibition decreased Ras
methylation and activity and the activation of the downstream signaling
molecules Akt, ERK-1, and ERK-2. Furthermore, overexpression of
wild-type or dominant active H-Ras blocked Ado/HC-induced apoptosis.
These findings suggest that inhibition of ICMT causes endothelial cell apoptosis by attenuation of Ras GTPase methylation and activation and
its downstream antiapoptotic signaling pathway.
Corresponding author. E-mail address:
Sharon_Rounds{at}brown.edu.
This article has been cited by other articles:
![]() |
Q. Lu Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5 Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L123 - L133. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Purohit, M. F Abdelmalek, S. Barve, N. J Benevenga, C. H Halsted, N. Kaplowitz, K. K Kharbanda, Q.-Y. Liu, S. C Lu, C. J McClain, et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium Am. J. Clinical Nutrition, July 1, 2007; 86(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, E. O. Harrington, J. Newton, M. Jankowich, and S. Rounds Inhibition of ICMT Induces Endothelial Cell Apoptosis through GRP94 Am. J. Respir. Cell Mol. Biol., July 1, 2007; 37(1): 20 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Winter-Vann, R. A. Baron, W. Wong, J. dela Cruz, J. D. York, D. M. Gooden, M. O. Bergo, S. G. Young, E. J. Toone, and P. J. Casey A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells PNAS, March 22, 2005; 102(12): 4336 - 4341. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Harrington, J. Newton, N. Morin, and S. Rounds Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1091 - L1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lu, E. O. Harrington, C.-M. Hai, J. Newton, M. Garber, T. Hirase, and S. Rounds Isoprenylcysteine Carboxyl Methyltransferase Modulates Endothelial Monolayer Permeability: Involvement of RhoA Carboxyl Methylation Circ. Res., February 20, 2004; 94(3): 306 - 315. [Abstract] [Full Text] [PDF] |
||||